The GLP-1 hydration products market is segmented by product type, functional focus, consumer stage, distribution channel, packaging format, end use, and region
A recent in vivo study in healthy subjects showed that acute intravenous infusion of GLP-1 during a pancreatic clamp, in which insulin and glucagon levels were maintained at basal levels, caused a reduction in hepatic glucose production, suggesting a potential direct effect on gluconeogenesis [11]
However, the increase in BAT recruitment apparently does not induce weight loss during long-term subcutaneous treatment with liraglutide in mice (Fig
By binding to GLP-1 receptors throughout the body, these medications enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and promote satiety
Several nonclinical studies using lean and DIO animal models consistently demonstrated reductions in food intake and body weight (80)
10.3390/ijms22084162 2 AkgunM.ErganB